Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SPF Control (often appearing as SFP Control in clinical documentation) refers to a standardized reference sunscreen formulation used by Bayer and other developers in clinical trials to calibrate and validate Sun Protection Factor (SPF) and UVA protection assays. In the context of Bayer's evaluations for experimental products like BAY987517, the SPF Control is applied to the skin of healthy volunteers at a standard density (typically 2 mg/cm²) to establish a benchmark for Minimal Erythema Dose (MED) or Minimal Persistent Pigment-Darkening Dose (MPPD). These formulations are strictly controlled according to regulatory standards (such as FDA or ISO guidelines) to ensure the reliability of UV exposure testing and to provide a consistent point of comparison for the efficacy of new sun protection agents in preventing sunburn and UV-induced skin damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SPF Control (Bayer).